- Clinicopathological Analysis of Hepatocellular Adenoma According to New Bordeaux Classification: Report of Eight Korean Cases
-
Hyunchul Kim, Ja-June Jang, Dong-Sik Kim, Beom Woo Yeom, Nam Hee Won
-
Korean J Pathol. 2013;47(5):411-417. Published online October 25, 2013
-
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.5.411
-
-
8,890
View
-
49
Download
-
7
Crossref
-
Abstract
PDF
- Background
Hepatocellular adenoma (HCA) is a rare benign tumor of the liver. A subtype classification of HCA (hepatocyte nuclear factor 1α [HNF1α]-mutated, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA) has recently been established based on a single institutional review of a HCA series by the Bordeaux group. MethodsWe used histologic and immunohistochemical parameters to classify and evaluate eight cases from our institution. We evaluated the new classification method and analyzed correlations between our results and those of other reports. ResultsSeven of our eight cases showed histologic and immunohistochemical results consistent with previous reports. However, one case showed overlapping histologic features, as previously described by the Bordeaux group. Four cases showed glutamine synthetase immunohistochemical staining inconsistent with their classification, indicating that glutamine synthetase staining may not be diagnostic for β-catenin-mutated HCA. HNF1α-mutated HCA may be indicated by the absence of liver fatty acid binding protein expression. Detection of amyloid A may indicate inflammatory HCA. HCA with no mutation in the HNF1α or β-catenin genes and no inflammatory protein expression is categorized as unclassified HCA. ConclusionsAlthough the new classification is now generally accepted, validation through follow-up studies is necessary.
-
Citations
Citations to this article as recorded by 
- Perinatal Management of Hepatic Adenomas
Megan A. Nocita, Carla W. Brady, Jeffrey A. Kuller, Luke A. Gatta Obstetrical & Gynecological Survey.2024; 79(12): 735. CrossRef - Relevance of morphological features for hepatocellular adenoma classification in pathology practice
Carla Henriques Agostini, Osmar Damasceno Ribeiro, Arlete Fernandes, Adriana Caroli-Bottino, Vera Lucia Pannain Surgical and Experimental Pathology.2020;[Epub] CrossRef - The molecular functions of hepatocyte nuclear factors – In and beyond the liver
Hwee Hui Lau, Natasha Hui Jin Ng, Larry Sai Weng Loo, Joanita Binte Jasmen, Adrian Kee Keong Teo Journal of Hepatology.2018; 68(5): 1033. CrossRef - Hepatocellular adenoma: Classification, variants and clinical relevance
Paulette Bioulac-Sage, Christine Sempoux, Charles Balabaud Seminars in Diagnostic Pathology.2017; 34(2): 112. CrossRef - A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice
Brent K. Larson, Maha Guindi American Journal of Clinical Pathology.2017; 147(6): 557. CrossRef - Hepatocellular Neoplasms Arising in Association With Androgen Use
Sounak Gupta, Bita V. Naini, Richard Munoz, Rondell P. Graham, Benjamin R. Kipp, Michael S. Torbenson, Taofic Mounajjed American Journal of Surgical Pathology.2016; 40(4): 454. CrossRef - Pigmented hepatocellular adenomas have a high risk of atypia and malignancy
Taofic Mounajjed, Saba Yasir, Patrice A Aleff, Michael S Torbenson Modern Pathology.2015; 28(9): 1265. CrossRef
|